Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis

Caiqing Mo, Wanida Chearwae, John T. O'Malley, Suzanne M. Adams, Saravanan Kanakasabai, Crystal C. Walline, Gretta L. Stritesky, Seth R. Good, Narayanan B. Perumal, Mark Kaplan, John J. Bright

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Experimental allergic encephalomyelitis (EAE) is a T cell-mediated autoimmune disease model of multiple sclerosis. Signal transducer and activator of transcription 4 (Stat4) is a transcription factor activated by IL-12 and IL-23, two cytokines known to play important roles in the pathogenesis of EAE by inducing T cells to secrete IFN-γ and IL-17, respectively. We and others have previously shown that therapeutic intervention or targeted disruption of Stat4 was effective in ameliorating EAE. Recently, a splice variant of Stat4 termed Stat4β has been characterized that lacks 44 amino acids at the C terminus of the full-length Stat4α. In this study we examined whether T cells expressing either isoform could affect the pathogenesis of EAE. We found that transgenic mice expressing Stat4β on a Stat4-deficient background develop an exacerbated EAE compared with wild-type mice following immunization with myelin oligodendrocyte glycoprotein peptide 35-55, while Stat4α transgenic mice have greatly attenuated disease. The differential development of EAE in transgenic mice correlates with increased IFN-γ and IL-17 in Stat4β-expressing cells in situ, contrasting increased IL-10 production by Stat4α-expressing cells. This study demonstrates that Stat4 isoforms differentially regulate inflammatory cytokines in association with distinct effects on the onset and severity of EAE.

Original languageEnglish
Pages (from-to)5681-5690
Number of pages10
JournalJournal of Immunology
Volume181
Issue number8
StatePublished - 2008

Fingerprint

STAT4 Transcription Factor
Autoimmune Experimental Encephalomyelitis
Demyelinating Diseases
Protein Isoforms
Inflammation
Transgenic Mice
Interleukin-17
T-Lymphocytes
Cytokines
Interleukin-23
Interleukin-12
Interleukin-10

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Mo, C., Chearwae, W., O'Malley, J. T., Adams, S. M., Kanakasabai, S., Walline, C. C., ... Bright, J. J. (2008). Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis. Journal of Immunology, 181(8), 5681-5690.

Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis. / Mo, Caiqing; Chearwae, Wanida; O'Malley, John T.; Adams, Suzanne M.; Kanakasabai, Saravanan; Walline, Crystal C.; Stritesky, Gretta L.; Good, Seth R.; Perumal, Narayanan B.; Kaplan, Mark; Bright, John J.

In: Journal of Immunology, Vol. 181, No. 8, 2008, p. 5681-5690.

Research output: Contribution to journalArticle

Mo, C, Chearwae, W, O'Malley, JT, Adams, SM, Kanakasabai, S, Walline, CC, Stritesky, GL, Good, SR, Perumal, NB, Kaplan, M & Bright, JJ 2008, 'Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis', Journal of Immunology, vol. 181, no. 8, pp. 5681-5690.
Mo C, Chearwae W, O'Malley JT, Adams SM, Kanakasabai S, Walline CC et al. Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis. Journal of Immunology. 2008;181(8):5681-5690.
Mo, Caiqing ; Chearwae, Wanida ; O'Malley, John T. ; Adams, Suzanne M. ; Kanakasabai, Saravanan ; Walline, Crystal C. ; Stritesky, Gretta L. ; Good, Seth R. ; Perumal, Narayanan B. ; Kaplan, Mark ; Bright, John J. / Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis. In: Journal of Immunology. 2008 ; Vol. 181, No. 8. pp. 5681-5690.
@article{7538fb82b03043f098b2085c2f652564,
title = "Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis",
abstract = "Experimental allergic encephalomyelitis (EAE) is a T cell-mediated autoimmune disease model of multiple sclerosis. Signal transducer and activator of transcription 4 (Stat4) is a transcription factor activated by IL-12 and IL-23, two cytokines known to play important roles in the pathogenesis of EAE by inducing T cells to secrete IFN-γ and IL-17, respectively. We and others have previously shown that therapeutic intervention or targeted disruption of Stat4 was effective in ameliorating EAE. Recently, a splice variant of Stat4 termed Stat4β has been characterized that lacks 44 amino acids at the C terminus of the full-length Stat4α. In this study we examined whether T cells expressing either isoform could affect the pathogenesis of EAE. We found that transgenic mice expressing Stat4β on a Stat4-deficient background develop an exacerbated EAE compared with wild-type mice following immunization with myelin oligodendrocyte glycoprotein peptide 35-55, while Stat4α transgenic mice have greatly attenuated disease. The differential development of EAE in transgenic mice correlates with increased IFN-γ and IL-17 in Stat4β-expressing cells in situ, contrasting increased IL-10 production by Stat4α-expressing cells. This study demonstrates that Stat4 isoforms differentially regulate inflammatory cytokines in association with distinct effects on the onset and severity of EAE.",
author = "Caiqing Mo and Wanida Chearwae and O'Malley, {John T.} and Adams, {Suzanne M.} and Saravanan Kanakasabai and Walline, {Crystal C.} and Stritesky, {Gretta L.} and Good, {Seth R.} and Perumal, {Narayanan B.} and Mark Kaplan and Bright, {John J.}",
year = "2008",
language = "English",
volume = "181",
pages = "5681--5690",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis

AU - Mo, Caiqing

AU - Chearwae, Wanida

AU - O'Malley, John T.

AU - Adams, Suzanne M.

AU - Kanakasabai, Saravanan

AU - Walline, Crystal C.

AU - Stritesky, Gretta L.

AU - Good, Seth R.

AU - Perumal, Narayanan B.

AU - Kaplan, Mark

AU - Bright, John J.

PY - 2008

Y1 - 2008

N2 - Experimental allergic encephalomyelitis (EAE) is a T cell-mediated autoimmune disease model of multiple sclerosis. Signal transducer and activator of transcription 4 (Stat4) is a transcription factor activated by IL-12 and IL-23, two cytokines known to play important roles in the pathogenesis of EAE by inducing T cells to secrete IFN-γ and IL-17, respectively. We and others have previously shown that therapeutic intervention or targeted disruption of Stat4 was effective in ameliorating EAE. Recently, a splice variant of Stat4 termed Stat4β has been characterized that lacks 44 amino acids at the C terminus of the full-length Stat4α. In this study we examined whether T cells expressing either isoform could affect the pathogenesis of EAE. We found that transgenic mice expressing Stat4β on a Stat4-deficient background develop an exacerbated EAE compared with wild-type mice following immunization with myelin oligodendrocyte glycoprotein peptide 35-55, while Stat4α transgenic mice have greatly attenuated disease. The differential development of EAE in transgenic mice correlates with increased IFN-γ and IL-17 in Stat4β-expressing cells in situ, contrasting increased IL-10 production by Stat4α-expressing cells. This study demonstrates that Stat4 isoforms differentially regulate inflammatory cytokines in association with distinct effects on the onset and severity of EAE.

AB - Experimental allergic encephalomyelitis (EAE) is a T cell-mediated autoimmune disease model of multiple sclerosis. Signal transducer and activator of transcription 4 (Stat4) is a transcription factor activated by IL-12 and IL-23, two cytokines known to play important roles in the pathogenesis of EAE by inducing T cells to secrete IFN-γ and IL-17, respectively. We and others have previously shown that therapeutic intervention or targeted disruption of Stat4 was effective in ameliorating EAE. Recently, a splice variant of Stat4 termed Stat4β has been characterized that lacks 44 amino acids at the C terminus of the full-length Stat4α. In this study we examined whether T cells expressing either isoform could affect the pathogenesis of EAE. We found that transgenic mice expressing Stat4β on a Stat4-deficient background develop an exacerbated EAE compared with wild-type mice following immunization with myelin oligodendrocyte glycoprotein peptide 35-55, while Stat4α transgenic mice have greatly attenuated disease. The differential development of EAE in transgenic mice correlates with increased IFN-γ and IL-17 in Stat4β-expressing cells in situ, contrasting increased IL-10 production by Stat4α-expressing cells. This study demonstrates that Stat4 isoforms differentially regulate inflammatory cytokines in association with distinct effects on the onset and severity of EAE.

UR - http://www.scopus.com/inward/record.url?scp=54049155063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049155063&partnerID=8YFLogxK

M3 - Article

VL - 181

SP - 5681

EP - 5690

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -